- Mitsubishi Chemical Group (Chicago, IL)
- …markets. In the United States, MTPA launched rare diseases treatments including RADICAVA( R ) (edaravone) injectables in 2017, EXSERVAN (TM) (riluzole) oral film in ... 2021, and RADICAVA( R ) (edaravone) oral suspension in 2022. The company handles...assigned specialty distributor and specialty pharmacy accounts. The Associate Director of Trade will collaborate with members of Supply… more